Clinical Trial Update: Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating Carmustine in adults with recurrent supratentorial low-grade glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Glioma

Drugs mentioned

• Carmustine (BiCNU) (carmustine)

Snippet

Sponsor: Duke University | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED